• Japanese
  • Korean
  • Chinese
Home > Publishers > La Merie Publishing
Publisher
Filter

La Merie Publishing Report List

La Merie Business Intelligence was established in 2002 by Ulrich Martin, MD, based on his extensive experience in the biopharmaceutical industry both as a physician specializing in pharmacology and as a co-founder and CEO of a product development biotech company. The focus of our reports and subscription services such as databases and periodicals is directed towards biologs as therapeutics, such as antibodies, proteins, peptides, vaccines and biosimilars. Today we continue to publish reports, but leverage our experience, knowledge and report writing expertise to offer this service to individual customers.

Filter
Title Search
1 - 25 of 32 Products Sort by Display
Reports Bundle: T-Cell Immunotherapy by Bispecific Antibodies and CAR & TCR Engineered T-Cells (Two Reports released in 2016)
Published by
La Merie Publishing
Product code
368816
Published
September 1, 2016
Content info
 
Price
USD 3400
Sample available
B-Cell Maturation Antigen (BCMA): Hot Target for Emerging Treatment Modalities
Published by
La Merie Publishing
Product code
369011
Published
August 31, 2016
Content info
39 Pages
Price
USD 570
Sample available
CD123: A Paradigmatic Target for Immunotherapeutic Treatment Modalities
Published by
La Merie Publishing
Product code
369010
Published
August 31, 2016
Content info
83 Pages
Price
USD 800
Sample available
TCR & CAR Engineered T-Cell and NK Cell Therapeutics 2016: Convergence of Technologies Opens Business Opportunities Beyond CD19 CARTs
Published by
La Merie Publishing
Product code
366651
Published
August 7, 2016
Content info
388 Pages
Price
USD 2750
Sample available
R&D and Business Tracker for Antibody-Drug Conjugates
Published by
La Merie Publishing
Product code
370244
Published
annual subscription
Content info
 
Price
USD 1350
Sample available
R&D and Business Tracker for Bispecific Antibodies
Published by
La Merie Publishing
Product code
370243
Published
annual subscription
Content info
 
Price
USD 1350
Sample available
R&D and Business Tracker for TCR & CAR T-Cells and NK Cells
Published by
La Merie Publishing
Product code
370242
Published
annual subscription
Content info
 
Price
USD 1350
Sample available
*
Published by
La Merie Publishing
Product code
318570
Published
annual subscription
Content info
 
Price
USD 1000
Sample available
*
Published by
La Merie Publishing
Product code
302689
Published
annual subscription
Content info
 
Price
USD 7565
Sample available
*
Published by
La Merie Publishing
Product code
276496
Published
annual subscription
Content info
1 Year Access to All Reports
Price
USD 5043
Sample available
*
Published by
La Merie Publishing
Product code
276495
Published
annual subscription
Content info
 
Price
USD 1600
Sample available
*
Published by
La Merie Publishing
Product code
216725
Published
annual subscription
Content info
 
Price
USD 1261
Sample available
*
Published by
La Merie Publishing
Product code
166718
Published
annual subscription
Content info
 
Price
USD 1513
Sample available
*
Published by
La Merie Publishing
Product code
359751
Published
June 9, 2016
Content info
 
Price
USD 3500
Sample available
Competitor Analysis: Biosimilar & Biosuperior Therapeutic Antibodies - 2016 Update
Published by
La Merie Publishing
Product code
327820
Published
May 25, 2016
Content info
462 Pages
Price
USD 1450
Sample available
T-Cell Redirecting Bispecific Antibodies 2016: A Competitive Landscape Analysis of Stakeholders, Technologies, Pipelines and Deals
Published by
La Merie Publishing
Product code
357780
Published
May 11, 2016
Content info
230 Pages
Price
USD 2400
Sample available
Competitor Analysis: Anti-VEGF/R Biosimilars and Biosuperiors of Avastin, Cyramza, Eylea and Lucentis - 2016 Update
Published by
La Merie Publishing
Product code
358307
Published
February 29, 2016
Content info
46 Pages
Price
USD 440
Sample available
RORgamma Modulators 2016: A Comparative Analysis of the Landscape of RORgamma Antagonists and Agonists
Published by
La Merie Publishing
Product code
351304
Published
February 3, 2016
Content info
88 Pages
Price
USD 1050
Sample available
Antibody-Drug Conjugates 2016: Perspectives & Opportunities - A Pipeline, Technology, Stakeholder & Business Analysis
Published by
La Merie Publishing
Product code
294276
Published
November 30, 2015
Content info
470 Pages
Price
USD 2500
Sample available
Engineered TCR and CAR Immunotherapeutics 2015
Published by
La Merie Publishing
Product code
325905
Published
March 13, 2015
Content info
201 Pages
Price
USD 2630
Sample available
Recombinant Coagulation Factors 2015: Maturation of Recombinant Clotting Factor Pipeline and Emergence of Gene Therapy and Alternative Procoagulants
Published by
La Merie Publishing
Product code
274454
Published
December 22, 2014
Content info
210 Pages
Price
USD 2795
Sample available
Botulinum Neurotoxins: A Comparative Industry Analysis of Products, Pipelines, Technologies and Stakeholders
Published by
La Merie Publishing
Product code
308429
Published
July 18, 2014
Content info
169 Pages
Price
USD 2459
Sample available
Competitor Analysis: Cancer Vaccines
Published by
La Merie Publishing
Product code
221876
Published
March 24, 2014
Content info
179 Pages
Price
USD 1112
Sample available
The Engineered T-Cell Receptor in Fusion Proteins, Antibodies & Cells: Emerging Opportunities for the Biopharmaceutical Industry
Published by
La Merie Publishing
Product code
288582
Published
October 25, 2013
Content info
84 Pages
Price
USD 1829
Sample available
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Published by
La Merie Publishing
Product code
146105
Published
May 1, 2013
Content info
301 Pages
Price
USD 2018
Sample available